Npm1 Mutation | List of Frontiers open access articles

Original Research

Published on 06 Sep 2013

The Addition of All-Trans Retinoic Acid to Chemotherapy May Not Improve the Outcome of Patient with NPM1 Mutated Acute Myeloid Leukemia

in Hematologic Malignancies

Aziz Nazha
Carlos Bueso - Ramos
Eli Estey
Stefan Faderl
Susan O'Brien
Micheal Fernandez
Martin Nguyen
Charles Koller
Emil Freireich
Miloslav Beran

Frontiers in Oncology

doi 10.3389/fonc.2013.00218

5,991 views
21 citations

Original Research

Published on 08 Feb 2022

Mutant NPM1-Regulated FTO-Mediated m6A Demethylation Promotes Leukemic Cell Survival via PDGFRB/ERK Signaling Axis

in Hematologic Malignancies

Qiaoling Xiao
Li Lei
Jun Ren
Meixi Peng
Yipei Jing
Xueke Jiang
Junpeng Huang
Yonghong Tao
Can Lin
Jing Yang

Frontiers in Oncology

doi 10.3389/fonc.2022.817584

6,555 views
29 citations

Original Research

Published on 09 Sep 2014

High-Resolution Melting Curve Analysis, a Rapid and Affordable Method for Mutation Analysis in Childhood Acute Myeloid Leukemia

in Pediatric Oncology

Yin Liu
Jingyan Tang
Peter Wakamatsu
Huiliang Xue
Jing Chen
Paul S. Gaynon
Shuhong Shen
Weili Sun

Frontiers in Pediatrics

doi 10.3389/fped.2014.00096

10,166 views
11 citations

Original Research

Published on 08 Nov 2024

Immune-based subgroups uncover diverse tumor immunogenicity and implications for prognosis and precision therapy in acute myeloid leukemia

in Cancer Immunity and Immunotherapy

Tingting Chen
Yue Zhang
Danyang Zhang
Hebing Zhou

Frontiers in Immunology

doi 10.3389/fimmu.2024.1451486

5,398 views
4 citations

Original Research

Published on 04 Apr 2025

Biological characteristics and prognosis of acute myeloid leukemia in elderly patients

in Cancer Genetics and Oncogenomics

Zhe Chen
Lina Ding
Jieni Yu
Jing Jin
Zhijian Zhang
Jiaping Fu
Pan Hong
Leihua Fu

Frontiers in Genetics

doi 10.3389/fgene.2025.1524177

2,380 views

Original Research

Published on 30 Aug 2021

Comparison of Multiple Clinical Testing Modalities for Assessment of NPM1-Mutant AML

in Hematologic Malignancies

Amanda Lopez
Sanjay Patel
Julia T. Geyer
Joelle Racchumi
Amy Chadburn
Paul Simonson
Madhu M. Ouseph
Giorgio Inghirami
Nuria Mencia-Trinchant
Monica L. Guzman

Frontiers in Oncology

doi 10.3389/fonc.2021.701318

8,978 views
17 citations

Articles

The Addition of All-Trans Retinoic Acid to Chemotherapy May Not Improve the Outcome of Patient with NPM1 Mutated Acute Myeloid Leukemia

Mutant NPM1-Regulated FTO-Mediated m6A Demethylation Promotes Leukemic Cell Survival via PDGFRB/ERK Signaling Axis

High-Resolution Melting Curve Analysis, a Rapid and Affordable Method for Mutation Analysis in Childhood Acute Myeloid Leukemia

Immune-based subgroups uncover diverse tumor immunogenicity and implications for prognosis and precision therapy in acute myeloid leukemia

Biological characteristics and prognosis of acute myeloid leukemia in elderly patients

Comparison of Multiple Clinical Testing Modalities for Assessment of NPM1-Mutant AML